Search for: "Galderma Laboratories, LP"
Results 1 - 4 of 4
Sorted by Relevance | Sort by Date
9 Oct 9:11 am
... of State University of New York, New York University, Galderma Laboratories, Galderma
Laboratories LP v. Impax Laboratories (patent infringement) 9/18: Ricoh Company Ltd. ... (patent infringement) 9/25: Cephalon
Inc. v. Watson Pharmaceuticals Inc., Watson Laboratories, Inc. and Watson Pharma Inc. (patent infringement) 10/5: Fairchild Semiconductor ... Company v. PLIVA-HRVATSKA d.o.o,
PLIVA d.d., Barr Laboratories Inc., Barr Pharmaceuticals Inc., Barr Pharmaceuticals, LLC, et al. (patent infringement) ...
22 Jun 12:23 am
... to a justiciable controversy. Thus, [the third-party plaintiff's] broad claims that the [third-party defendant's New Drug Application] and the listing of the [patent-in-suit]
adversely affected its ability to market [its product] do not give rise to a justiciable controversy." Galderma Laboratories,
LP et al v. Paddock Laboratories Inc., 4-09-cv-00002 (TXND June 18, 2009, Order) (Means, J.)
24 Feb, 2008 8:47 pm
By Sherri Oslick -- About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic
monitoring. Galderma Laboratories, LP et al. v. Actavis Mid-Atlantic, L.L.C. 4:08-cv-00115;
filed February 21, 2008 in the Northern District of...
16 Jan 5:00 am
... infringement suit against Lupin over Antara (Law360) (GenericsWeb) Clobex (Clobetasol propionate) - US: Galderma files patent infringement
suit against Paddock Laboratories to block generic Clobex (Law360) Effexor (Venlafaxine) - US: Wyeth files ... its generic Pataday ANDA submission (Law360) Perforomist
(Formoterol) - US: PTO issues Mylan's subsidiary Dey LP three additional patents protecting Perforomist (SmartBrief) Seroquel (Quetiapine) -
US: AstraZeneca files patent infringement suit against ...
Search on: Blawgs.FM | BlawgSearch Google Co-op |
Blawg.com | Bloglines | Feedster | Google Blog Search |
Technorati | Google | MSN | Yahoo!











